A 82695
Latest Information Update: 24 Jan 2013
At a glance
- Originator Abbott Laboratories
- Class Anxiolytics; Neuroprotectants; Nootropics
- Mechanism of Action Nicotinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 15 Mar 2001 No-Development-Reported for Cognition disorders in USA (Unknown route)
- 20 Jan 1997 Preclinical development for Cognition disorders in USA (Unknown route)